American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Messino Cancer Centers (MCC), as a second strategic research site. Hematology/Oncology Clinic (HOC) in Baton Rouge, La., also a partner practice of AON, was the first strategic research site under this partnership.
Messino Cancer Centers (MCC), a partner practice of American Oncology Network, LLC (AON), recently aligned with the Sarah Cannon Research Institute, a global leader in offering community-based clinical trials.
Waverly Oncology Hematology (Waverly), an American Oncology Network, LLC (AON) partner, recently announced that the Journal of Clinical Oncology (JCO) has published the full results of the landmark MonarchE trial of abemaciclib (Verzenio®) combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high risk, early breast cancer.
American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings, recently cut the ribbon on a new state-of-the-art specialty pharmacy to better serve its growing network of community-based oncology practices and cancer patients.
Each day, American Oncology Network (AON) employees are doing everything they can to make sure our patients are as comfortable as possible as they undergo treatment. This includes the dedicated and knowledgeable team working at our centralized, state-of-the-art pharmacy, which is celebrating its two-year anniversary.
Breast cancer is the second-most common form of cancer in women with 13% expected to develop the disease at some time in their life. Breast cancer can also happen to men — though it makes up for 1% or less of all breast cancer diagnoses.
American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings, recently announced the appointment of Kristin Matisziw as the organization’s corporate compliance officer.
Cancer treatments can prove costly, especially if patients must travel far for treatment or are prescribed expensive medications. And that financial burden can create enormous stress.
merican Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of cancer treatment in community-based settings, today announced that it has appointed David H. Gould, CPA as Chief Financial Officer.
American Oncology Network, LLC (AON) is pleased to announce that a research study led by AON physician Ruemu E. Birhiray, MD of Hematology Oncology of Indiana, was accepted for presentation at the annual meeting of the Society of Hematologic Oncology (SOHO), to be held as a virtual event, September 9 – 12, 2020.
14543 Global Parkway
Suite 110
Fort Myers, FL 33913